Furthermore, Bates et al. (2006) showed that high numbers of tumor-infiltrating Treg cells is an independent prognostic factor for shorter recurrence-free survival and overall survival in patients with ER+ breast cancers [39]. The gene discussed is ESR1; the disease is breast carcinoma.